AptaBio Therapeutics Inc (293780) — Financial Flexibility Index
AptaBio Therapeutics Inc (293780) has a Financial Flexibility Index of -0.12x as of September 2025. Free cash flow of ₩-2.71 Billion (operating CF ₩-2.73 Billion minus capex ₩16.17 Million) represents 0% of total liabilities (₩22.51 Billion). Also explore net asset growth rate of AptaBio Therapeutics Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AptaBio Therapeutics Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for AptaBio Therapeutics Inc across 8 annual periods. Check 293780 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for AptaBio Therapeutics Inc (2017–2024)
Year-by-year free cash flow to debt coverage for AptaBio Therapeutics Inc. For the full company profile including market capitalisation, see how much is AptaBio Therapeutics Inc worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.51x | ₩-11.92 Billion | ₩-12.16 Billion | ₩23.24 Billion | ▼ -14.7% |
| 2023 | -0.45x | ₩-13.93 Billion | ₩-14.10 Billion | ₩31.16 Billion | ▲ +71.1% |
| 2022 | -1.55x | ₩-5.79 Billion | ₩-6.83 Billion | ₩3.74 Billion | ▲ +42.5% |
| 2021 | -2.69x | ₩-8.74 Billion | ₩-8.90 Billion | ₩3.25 Billion | ▼ -337.5% |
| 2020 | -0.62x | ₩-2.09 Billion | ₩-3.79 Billion | ₩3.40 Billion | ▲ +57.0% |
| 2019 | -1.43x | ₩-3.22 Billion | ₩-6.00 Billion | ₩2.25 Billion | ▼ -67.7% |
| 2018 | -0.85x | ₩-1.72 Billion | ₩-1.75 Billion | ₩2.02 Billion | ▼ -1937.4% |
| 2017 | -0.04x | ₩-1.78 Billion | ₩-1.79 Billion | ₩42.54 Billion | — |